147 related articles for article (PubMed ID: 10621157)
21. Risk contractors take aim at skyrocketing drug costs.
Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
[No Abstract] [Full Text] [Related]
22. Medicare risk programs and pharmacy benefits managers.
Herzfeld J
Med Interface; 1996 Dec; 9(12):75-8. PubMed ID: 10172875
[TBL] [Abstract][Full Text] [Related]
23. Medicare drug beneficiaries and cost-lowering strategies.
Bjarnason NH; Kampmann JP
JAMA; 2005 Feb; 293(5):552-3; author reply 553. PubMed ID: 15687306
[No Abstract] [Full Text] [Related]
24. Pharmacy benefit management as a quality safeguard.
Giaquinta D
Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
[No Abstract] [Full Text] [Related]
25. New standard for pharmacy benefits.
Walgran CC
J Health Care Benefits; 1994; 3(3):60-4. PubMed ID: 10131221
[No Abstract] [Full Text] [Related]
26. Survey highlights trends in managing Medicare drug costs.
Public Sect Contract Rep; 1998 Aug; 4(8):125-7. PubMed ID: 10182909
[TBL] [Abstract][Full Text] [Related]
27. Influencing drug formulary and contract performance.
Navarro RP
Manag Care Interface; 1999 Apr; 12(4):89-91, 96. PubMed ID: 10387398
[No Abstract] [Full Text] [Related]
28. The Pharmaceutical Management Panel - highlights of the pharmacy business.
Kirshenbaum D
Dis Manag; 2003; 6(Suppl 1):S15-7. PubMed ID: 14751024
[No Abstract] [Full Text] [Related]
29. Pharmacy benefit starts to reflect push for consumer-directed care.
Berberabe T
Manag Care; 2003 Sep; 12(9):29-32. PubMed ID: 14528670
[No Abstract] [Full Text] [Related]
30. Cost not the primary factor driving drug coverage.
Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
[No Abstract] [Full Text] [Related]
31. The evolving role of pharmacy benefits management firms in a managed care environment.
O'Leary JS
Benefits Q; 1995; 11(3):24-33. PubMed ID: 10151118
[TBL] [Abstract][Full Text] [Related]
32. Defined-contribution products and their influence on pharmacy benefit management.
Giaquinta D
Manag Care Interface; 2003 Aug; 16(8):36-8. PubMed ID: 12964551
[No Abstract] [Full Text] [Related]
33. Rebates and other drug-cost issues.
Penna P
Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863
[No Abstract] [Full Text] [Related]
34. Medicaid prescription drug coverage: state efforts to control costs.
Gencarelli DM
NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
[TBL] [Abstract][Full Text] [Related]
35. The emerging specialty pharmaceutical market segment.
Giaquinta D
Manag Care Interface; 2003 Apr; 16(4):35-6. PubMed ID: 12747139
[No Abstract] [Full Text] [Related]
36. Capitation risks for pharmacy services.
Navarro RP
Med Interface; 1994 Jul; 7(7):88-90. PubMed ID: 10135996
[TBL] [Abstract][Full Text] [Related]
37. The managed care prescription benefit. Challenged by shifting care and shifting costs.
Bender J
AAPPO J; 1991; 1(4):11-8. PubMed ID: 10149632
[No Abstract] [Full Text] [Related]
38. Exportation of U.S. pharmacy benefit management companies to Canada.
Navarro RP
Med Interface; 1995 Jul; 8(7):72-4. PubMed ID: 10143827
[No Abstract] [Full Text] [Related]
39. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
40. Mass customization--the next generation of pharmacy management.
Chao S
Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
